Roche. Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease. 2026 Feb 16. Accessed 2026 Feb 16.
During a live event, Hagen Kennecke, MD, discusses how RADIANT-4 and NETTER trials have reshaped NET care with everolimus and ...
Real-time strategy games are usually about conquest. You expand your influence through various means to ultimately crush your opposition, as your economy and military scale out of control. The genre ...
NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...
Blind boxes and bags aren’t new, but intentional design keeps the format exciting for retailers, kids, and collectors alike.
The middle meningeal artery (MMA) has emerged as a potential therapeutic target for severe, treatment-resistant headache ...
Background Adults with Tourette syndrome (ATS) face increased risks of self-injury behaviours (SIBs) and suicidality, yet research has largely focused on biological factors. Despite stigma being a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results